Journal
JOURNAL OF PHARMACEUTICAL ANALYSIS
Volume 12, Issue 4, Pages 541-555Publisher
ELSEVIER
DOI: 10.1016/j.jpha.2021.10.003
Keywords
Berberine; Gut microbiota; Oral bioavailability; Traditional Chinese medicines; Short chain fatty acids
Categories
Funding
- National Natural Science Foundation of China [81891012, 82104409, 81891010, 81630101, U19A2010]
- Science and Technology Ministry of China [2108ZX09721001-0 08]
- China Postdoctoral Science Foundation [2021M690490]
- Sichuan Science and Technology Program [2021YJ0466]
- Open Research Fund of Chengdu University of Traditional Chinese Medicine Key Labo- ratory of Systematic Research of Distinctive Chinese Medicine Re- sources in Southwest China [2020BSH003, BSH2020017]
- Open Research Fund of Chengdu University of Traditional Chinese Medicine Key Laboratory of Systematic Research of Distinctive Chinese Medicine Re- sources in Southwest China [BSH2020017]
- Xinglin Scholar Plan of Chengdu University of Traditional Chinese Medicine [2020BSH003]
Ask authors/readers for more resources
This review provides a systematic and comprehensive summary of the interactions between berberine (BBR) and gut microbiota, as well as their corresponding influences on pharmacological effects. The review discusses the regulatory effects of BBR on gut microbiota composition and metabolism, the metabolism of BBR by gut microbiota, the complex interactions between gut microbiota and BBR, as well as the side effects and personalized use of BBR. The review also presents future research directions regarding BBR and gut microbiota.
Berberine (BBR), an isoquinoline alkaloid, has been found in many plants, such as Coptis chinensis Franch and Phellodendron chinense Schneid. Although BBR has a wide spectrum of pharmacological effects, its oral bioavailability is extremely low. In recent years, gut microbiota has emerged as a cynosure to un-derstand the mechanisms of action of herbal compounds. Numerous studies have demonstrated that due to its low bioavailability, BBR can interact with the gut microbiota, thereby exhibiting altered pharma-cological effects. However, no systematic and comprehensive review has summarized these interactions and their corresponding influences on pharmacological effects. Here, we describe the direct interactive relationships between BBR and gut microbiota, including regulation of gut microbiota composition and metabolism by BBR and metabolization of BBR by gut microbiota. In addition, the complex interactions between gut microbiota and BBR as well as the side effects and personalized use of BBR are discussed. Furthermore, we provide our viewpoint on future research directions regarding BBR and gut microbiota. This review not only helps to explain the mechanisms underlying BBR activity but also provides support for the rational use of BBR in clinical practice.(c) 2021 The Authors. Published by Elsevier B.V. on behalf of Xi'an Jiaotong University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available